| Defining KIR and HLA class I genotypes at highest resolution via high-throughput sequencing PJ Norman, JA Hollenbach, N Nemat-Gorgani, WM Marin, SJ Norberg, ... The American Journal of Human Genetics 99 (2), 375-391, 2016 | 147 | 2016 |
| Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis VR Bonagura, Z Du, E Ashouri, L Luo, LJ Hatam, JA DeVoti, ... Human immunology 71 (2), 212-219, 2010 | 101 | 2010 |
| KIR gene content diversity in four Iranian populations E Ashouri, S Farjadian, EF Reed, A Ghaderi, R Rajalingam Immunogenetics 61, 483-492, 2009 | 78 | 2009 |
| A novel duplex SSP–PCR typing method for KIR gene profiling E Ashouri, A Ghaderi, EF Reed, R Rajalingam Tissue antigens 74 (1), 62-67, 2009 | 70 | 2009 |
| Antitumor activity and apoptosis induction in human cancer cell lines by Dionysia termeana Z Amirghofran, M Bahmani, A Azadmehr, E Ashouri, K Javidnia Cancer investigation 25 (7), 550-554, 2007 | 34 | 2007 |
| Killer Cell Immunoglobulin-like Receptors in HLA-B27–Associated Acute Anterior Uveitis, with and without Axial Spondyloarthropathy RD Levinson, TM Martin, L Luo, E Ashouri, JT Rosenbaum, JR Smith, ... Investigative ophthalmology & visual science 51 (3), 1505-1510, 2010 | 32 | 2010 |
| Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt–Koyanagi–Harada syndrome in Japanese individuals RD Levinson, AA Okada, E Ashouri, H Keino, R Rajalingam Human immunology 71 (2), 192-194, 2010 | 30 | 2010 |
| Activating KIR2DS5 receptor is a risk for thyroid cancer E Ashouri, MH Dabbaghmanesh, S Rowhanirad, M Bakhshayeshkaram, ... Human Immunology 73 (10), 1017-1022, 2012 | 26 | 2012 |
| The impact of LRP5 polymorphism (rs556442) on calcium homeostasis, bone mineral density, and body composition in Iranian children E Ashouri, EM Meimandi, F Saki, MH Dabbaghmanesh, GR Omrani, ... Journal of bone and mineral metabolism 33, 651-657, 2015 | 25 | 2015 |
| KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians S Barani, B Khademi, E Ashouri, A Ghaderi Human immunology 79 (4), 218-223, 2018 | 23 | 2018 |
| Comparison of KIR gene content profiles revealed a difference between northern and southern Persians in the distribution of KIR2DS5 and its linked loci G Solgi, H Ghafari, E Ashouri, K Alimoghdam, R Rajalingam, ... Human immunology 72 (11), 1079-1083, 2011 | 19 | 2011 |
| KIR variation in Iranians combines high haplotype and allotype diversity with an abundance of functional inhibitory receptors C Alicata, E Ashouri, N Nemat-Gorgani, LA Guethlein, WM Marin, S Tao, ... Frontiers in Immunology 11, 556, 2020 | 18 | 2020 |
| Presence of more activating KIR genes is associated with Hashimoto’s thyroiditis E Ashouri, MH Dabbaghmanesh, G Ranjbar Omrani Endocrine 46, 519-525, 2014 | 18 | 2014 |
| KIR-HLA gene diversities and susceptibility to lung cancer M Hematian Larki, E Ashouri, S Barani, SMA Ghayumi, A Ghaderi, ... Scientific Reports 12 (1), 17237, 2022 | 13 | 2022 |
| HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands E Ashouri, PJ Norman, LA Guethlein, AS Han, N Nemat‐Gorgani, ... HLA 88 (3), 87-99, 2016 | 12 | 2016 |
| KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease RD Levinson, M Yung, A Meguro, E Ashouri, F Yu, N Mizuki, S Ohno, ... PLoS One 11 (8), e0160392, 2016 | 10 | 2016 |
| Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk E Ashouri, K Rajalingam, S Barani, S Farjadian, A Ghaderi, R Rajalingam Scientific reports 11 (1), 7932, 2021 | 9 | 2021 |
| Gene-specific PCR typing of killer cell immunoglobulin-like receptors R Rajalingam, E Ashouri Transplantation Immunology: Methods and Protocols, 239-255, 2013 | 5 | 2013 |
| Activating KIR receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis VR Bonagura, Z Du, E Ashouri, L Luo, LJ Hatam, JA DeVoti, ... Human immunology 71 (2), 212, 2010 | 3 | 2010 |
| KIR gene content does not contribute to susceptibility to Graves’ disease E Ashouri, MH Dabbaghmanesh, A Hadaegh, S Rowhanirad, ... Iranian Journal of Immunology 10 (3), 150-157, 2013 | 2 | 2013 |
